Real-world treatment patterns, survival outcomes, and health care resource utilization for locally advanced or metastatic urothelial carcinoma in Spain
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Real-world treatment patterns, survival outcomes, and health care resource utilization for locally advanced or metastatic urothelial carcinoma in Spain ; day:4 ; month:10 ; year:2024 ; pages:1-9
Clinical and translational oncology ; (4.10.2024), 1-9
- Urheber
-
Puente, Javier
Pinto, Alvaro
Mendez-Vidal, Maria José
García del Muro, Xavier
Maroto, Pablo
Vazquez, Sergio
Luque-Caro, Raquel
Anido, Urbano
Strunz-McKendry, Torsten
Upadhyay, Anil
Montes, Jose
Ortiz Nuñez, Aurora
González Portela, Judit
Castellano, Daniel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12094-024-03734-8
- URN
-
urn:nbn:de:101:1-2412202118425.083959834954
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Puente, Javier
- Pinto, Alvaro
- Mendez-Vidal, Maria José
- García del Muro, Xavier
- Maroto, Pablo
- Vazquez, Sergio
- Luque-Caro, Raquel
- Anido, Urbano
- Strunz-McKendry, Torsten
- Upadhyay, Anil
- Montes, Jose
- Ortiz Nuñez, Aurora
- González Portela, Judit
- Castellano, Daniel
- SpringerLink (Online service)
Ähnliche Objekte (12)
HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma
Comparison between urothelial and non-urothelial urethral cancer
Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study
Impact on healthcare resource utilization of multiple sclerosis in Spain
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding
Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain
Management of Locally Advanced Unresectable or Metastatic Urothelial Carcinoma: Expert Opinion from an Indian Panel via Delphi Consensus Method
Prediction of locally advanced urothelial carcinoma of the bladder using clinical parameters before radical cystectomy : a prospective multicenter study
A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma
Comparison between urothelial and non-urothelial urethral cancer
Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study
Impact on healthcare resource utilization of multiple sclerosis in Spain
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding
Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain
Management of Locally Advanced Unresectable or Metastatic Urothelial Carcinoma: Expert Opinion from an Indian Panel via Delphi Consensus Method
Prediction of locally advanced urothelial carcinoma of the bladder using clinical parameters before radical cystectomy : a prospective multicenter study
A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
Exposure–response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma
Comparison between urothelial and non-urothelial urethral cancer
Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study
Impact on healthcare resource utilization of multiple sclerosis in Spain
A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding
Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain
Management of Locally Advanced Unresectable or Metastatic Urothelial Carcinoma: Expert Opinion from an Indian Panel via Delphi Consensus Method
Prediction of locally advanced urothelial carcinoma of the bladder using clinical parameters before radical cystectomy : a prospective multicenter study
A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma